Jefferies Raises Price Target on Medtronic (MDT) to $100 Following 1Q Report

August 26, 2016 10:42 AM EDT
Get Alerts MDT Hot Sheet
Price: $75.82 --0%

Rating Summary:
    17 Buy, 19 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 10 | Down: 16 | New: 50
Trade MDT Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Jefferies reiterated a Buy rating on Medtronic, Inc. (NYSE: MDT), and raised the price target to $100.00 (from $93.00), following the company's 1Q earnings report. EPS was reported $0.02 above estimates. FX was only $7mn v. the $25- $75mn guided to and the company missed consensus by about $12mn.

Analyst Raj Denhoy commented, "The one fewer week confounded results in 1Q but sales growth came in at +5.1% and EPS beat by $0.02. Op margins of 26.4% were higher than the 25.7% expectation as the company kept margins flat after adjusting for the extra week, despite absorbing 100bp from FX. Revenue and EPS guidance was maintained. However, with currency now expected to be a positive $300mn, we think that EPS guidance could prove conservative."

For an analyst ratings summary and ratings history on Medtronic, Inc. click here. For more ratings news on Medtronic, Inc. click here.

Shares of Medtronic, Inc. closed at $85.39 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Jefferies & Co, Earnings

Add Your Comment